Connect with us

Legal & Regulation

New Bipartisan Bill Presented to Promote Cannabis Research Efforts

Published

on

New Bipartisan Bill Presented to Promote Cannabis Research Efforts

Representatives, Donna Shalala and Matt Gaetz have supposedly introduced a bipartisan bill that aims to find ways to reschedule cannabis, as it currently prevents researchers from studying the effectiveness of the plant’s numerous cannabinoids.

To be more specific, the Expanding Cannabis Research and Information Act is working towards de-scheduling cannabis from Schedule I of the Controlled Substances Act and instead putting it under Schedule III reports Grizzle.

The latter approach is expected to lighten researchers’ barrier to studying the plant, especially if it means that disputes between the federal government and states that have legalized medical cannabis use is surely to drop.

Shalala, who has been formerly known for taking on as the secretary of Health and Human Services, has since expressed the importance of understanding cannabis with respect to consumer wellness and how crucial it is for said findings to be concluded in the safest possible manner.

In particular, Shalala said:

“We are not only bringing federal cannabis policy […] but we’re also guaranteeing that we do so safely.”

The duo’s alliance doesn’t come too much of a surprise, as they are for changing the negative perspective of cannabis. While Shalala’s had a recent change of heart, Gaetz has always been putting in effort in order to make cannabis research possible so that both short and long-term benefits could be understood.

Andrew is a full-time professional writer in Canada with over 8 years of esteemed experience. He is one of the best cannabis health researchers, polished legal investigators and active CBD news reporters we have at TOC. While being featured in hundreds of health, technology, science, and even bitcoin publications; Andrew's now on the frontline of the Canadian cannabis culture and will continue breaking down everything so easily your grandma can understand hemp and CBD.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.